X4 Phar­ma­ceu­ti­cals pulls to­geth­er some pos­i­tive da­ta re­sults af­ter a rocky year

X4 Phar­ma­ceu­ti­cals said its rare dis­ease drug cleared a Phase III on Tues­day af­ter­noon, com­ing against a back­drop of lay­offs and pipeline prun­ing ear­li­er this …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER